.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Chinese Patent Office
Novartis
AstraZeneca
Federal Trade Commission
Mallinckrodt
Accenture
Deloitte
Boehringer Ingelheim
Dow

Generated: November 23, 2017

DrugPatentWatch Database Preview

Taro Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for TARO PHARMS, and what generic alternatives to TARO PHARMS drugs are available?

TARO PHARMS has four approved drugs.

There is one US patent protecting TARO PHARMS drugs.

There are fifteen patent family members on TARO PHARMS drugs in eleven countries.

Summary for Taro Pharms

International Patents:15
US Patents:1
Tradenames:5
Ingredients:4
NDAs:4
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro Pharms North
ACETAMINOPHEN
acetaminophen
SUPPOSITORY;RECTAL018337-003Sep 12, 1983OTCYesNo► Subscribe► Subscribe► Subscribe
Taro Pharms North
ACETAMINOPHEN
acetaminophen
SUPPOSITORY;RECTAL018337-001Approved Prior to Jan 1, 1982OTCYesYes► Subscribe► Subscribe► Subscribe
Taro Pharms Ireland
ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE
ondansetron hydrochloride
INJECTABLE;INJECTION078014-001Mar 21, 2008DISCNNoNo► Subscribe► Subscribe► Subscribe
Taro Pharms North
PSORCON
diflorasone diacetate
CREAM;TOPICAL020205-001Nov 20, 1992DISCNYesNo► Subscribe► Subscribe► Subscribe
Taro Pharms
PLIAGLIS
lidocaine; tetracaine
CREAM;TOPICAL021717-001Jun 29, 2006RXYesYes► Subscribe► SubscribeY ► Subscribe
Taro Pharms North
INFANTS' FEVERALL
acetaminophen
SUPPOSITORY;RECTAL018337-004Aug 26, 1992OTCYesNo► Subscribe► Subscribe► Subscribe
Taro Pharms North
ACETAMINOPHEN
acetaminophen
SUPPOSITORY;RECTAL018337-002Approved Prior to Jan 1, 1982OTCYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Taro Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Taro Pharms
PLIAGLIS
lidocaine; tetracaine
CREAM;TOPICAL021717-001Jun 29, 2006► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Taro Pharms Drugs

Country Document Number Estimated Expiration
Australia7719800► Subscribe
Austria345757► Subscribe
European Patent Office1702597► Subscribe
China100367927► Subscribe
Denmark1244401► Subscribe
Canada2386017► Subscribe
European Patent Office1244401► Subscribe
Japan2003510259► Subscribe
Japan2007217431► Subscribe
Japan2012246315► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Farmers Insurance
UBS
Argus Health
US Army
Covington
Merck
Dow
US Department of Justice
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot